708 event(s) found
EUnetCCC 2026 Annual Meeting (European Network of Comprehensive Cancer Centres)
Second annual meeting of the EU Joint Action EUnetCCC (163 partners, 31 countries) coordinated by INCa, sharing first results of the network of comprehensive cancer centres combining care, research, prevention and training.
3e Journée annuelle du Réseau universitaire d'hématologie HORUS
Third annual day of the HORUS university hematology network (Lorraine) for physicians, pharmacists and nurses: network advances, city-hospital coordination, home hospitalisation, hematology-pharmacy cooperation and research activities.
2026 Shanghai Medical Association Oncology Branch Annual Meeting (2026年上海市医学会肿瘤专科分会学术年会)
One-day annual scientific meeting of the Shanghai Medical Association's oncology branch. Regional (municipal) society meeting.
44th Annual Meeting of the Japan Society for Neuro-Oncology (第44回日本脳腫瘍学会学術集会)
Annual national meeting on brain tumours covering neurosurgery, neuro-pathology, radiotherapy and systemic treatment.
TROG Cancer Research Concept Development Workshop 2026
Virtual half-day workshop helping TROG members turn radiation oncology trial ideas into fully developed research concepts.
EACR Virtual Conference: Systems-level Engineering of T-cell Specificity
European Association for Cancer Research event: Systems-level Engineering of T-cell Specificity.
27th Annual Meeting of the Society of Urologic Oncology
More information coming soon...
PSCC Hack4Hope - 3rd Edition
Pediatric cancer innovation hackathon of the PSCC Childhood Cancer Working Group: 10 pre-selected projects receive expert mentoring then pitch to an international jury; prize money (EUR 180,000 shared in the previous edition).
67th Annual Meeting of the Japan Lung Cancer Society (第67回日本肺癌学会学術集会)
National multidisciplinary congress on thoracic oncology covering lung cancer screening, surgery, radiotherapy, systemic therapy and pathology.
X Annual Conference with International Participation 'Evolution of Drug Therapy for Malignant Tumours' (X ежегодная конференция с международным участием «Эволюция лекарственной терапии злокачественных опухолей»)
Tenth annual Petrov Center conference reviewing advances in systemic anticancer therapy (chemotherapy, targeted agents and immunotherapy), with international speakers.
ESMO Asia Congress 2026
ESMO's Asian congress uniting oncology specialists from Asia-Pacific and worldwide on the most prevalent cancers in Asia, with a focus on multidisciplinary care, molecular oncology, biomarker-driven targeted therapies and AI in clinical practice.
IASLC/ASCO 2026 North America Conference on Lung Cancer (NACLC26)
Joint IASLC-ASCO North American lung cancer conference with scientific sessions, industry symposia, posters and exhibit hall.
The 2026 Annual Meeting of Asian Society of Gynecologic Oncology (ASGO 2026)
Annual meeting of the Asian Society of Gynecologic Oncology, held in Shanghai and covering prevention, diagnosis and treatment of gynecological cancers across Asia.
AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer
Conference on liver cancer biology, immunotherapy, and translational research.
San Antonio Breast Cancer Symposium® (SABCS) 2026
49th annual international symposium on breast cancer biology, etiology, prevention, diagnosis and therapy, with about 10,000 attendees from over 100 countries. Co-directors: Carlos L. Arteaga and Virginia G. Kaklamani.
34e Congrès national de la Société Française d'Onco-Gynécologie (SFOG)
34th national congress of the French society of gynaecological oncology on the multidisciplinary management of gynaecological and breast cancers.
BioFIT 2026
European meeting point for technology transfer and sourcing of early-stage life science innovations: academia-industry partnering with 1,200+ participants from 35+ countries (pharma, biotech, tech-transfer offices, investors).
XXX Russian Oncology Congress with International Participation (XXX Российский онкологический конгресс с международным участием)
Flagship annual congress of Russian clinical oncology, co-organised by RUSSCO, the N.N. Blokhin NMRC of Oncology and the Association of Oncologists of Russia, covering all tumour types, haemato-oncology and supportive care, with a young scientists competition.
Clinical Laboratory Diagnostics in Hematology and Transfusiology – Scientific and Practical Conference with International Participation (Научно-практическая конференция с международным участием «Клиническая лабораторная диагностика в гематологии и трансфузиологии»)
Conference of the Russian Research Institute of Hematology and Transfusiology (FMBA) on laboratory diagnostic methods in hematology and transfusion medicine.
68th ASH Annual Meeting & Exposition
More information coming soon..
ESMO Immuno-Oncology & Advanced Therapies Congress 2026
Hybrid international ESMO congress spanning cancer immunology, immunotherapy, cell therapies, vaccines, biomarkers and advanced therapeutic strategies, for clinicians, scientists and translational researchers.
3rd Shanghai Medical Association Radiation Oncology Branch Symposium on Radiotherapy Physics and Technology 2026 (2026第三届上海市医学会肿瘤放疗分会放疗物理与技术专题会)
One-day symposium of the Shanghai Medical Association radiation oncology branch dedicated to radiotherapy physics and technology. Regional (municipal) society meeting.
AACR Special Conference in Cancer Research: Cancer Biology-informed Radioligand Therapy
The goal of this conference is to convene experts in cancer biology, immunotherapy, and radioligand therapy (RLT) to discuss approaches to treating cancer with radioligand therapies and explore synergies with other treatments. With significant effort and interest in radioligand therapy by academia, industry, and government, paradigm-changing studies have demonstrated that combining molecular imaging and RLT has the possibility to dramatically impact cancer treatment. However, the major limitation for the further development of this field is a lack of fundamental knowledge of the mechanism(s) of action of systemic therapeutic isotopes with tumors, the tumor microenvironment, and the immune system. This conference is needed to engage experts from these diverse areas to not only educate on the state-of-the-art in radiotheranostics, but also to leverage the knowledge of cancer biologists, clinical oncologists, and immunologists to understand how RLT approaches work and how to overcome their limitations to drive the development of next generation therapies. Advancing RLT requires multi-disciplinary effort, with critical input from experts in radiochemistry, instrumentation, nuclear physics, and radiation biology. An unmet need in the field is advanced understanding of systemic radiobiology and cancer immunology as linked to therapeutic isotopes to fill gaps in knowledge across these domains. This AACR conference will focus on bringing together experts in these areas to discuss: 1) novel mechanisms of action of how systemic beta- and alpha-emitting isotopes interact with tumors, TME and the whole body to affect cures; 2) how RLT engages the immune system to mediate therapeutic efficacy; 3) rational approaches to treating cancer with novel isotopes and repurposed radioligand therapies; and 4) novel combinations and synergies with targeted and cellular therapies as well as external beam radiation, leveraging the strengths of each. Understanding how RLT interacts with the TME and the immune system are key to advancing novel therapies to treat an array of cancers.
Biotech Showcase 2027
19th annual investor and partnering conference held during JPM week: 400+ presenting companies from seed stage to multinationals, investors representing $400bn+; virtual part on 19-20 January 2027.